August 11, 2025

Characterization of persistent COVID-19: An emerging post- pandemic crisis in immunocompromised patients. An observational cohort study

View Full Paper

Ask AI

Bookmark

Authors

SIShimon Izhakian VYVered Yahalom OEOfir EldarRabin Medical Center

Discussion

Member takes

Implication

Observational cohort study reveals high mortality rate and diagnostic challenges in patients with persistent covid-19, highlighting implications for treatment strategies.

Key Points

Persistent covid-19 significantly impacts immunocompromised patients, with a mortality rate of 24.6%.
The study included 81 patients, with hematological malignancies as the most common immunosuppressive condition at 62.9%.
Treatment commonly involved antiviral agents (83.9%) and convalescent plasma (95.0%), confirming the importance of multidisciplinary care.
Key symptoms included fever (80.2%) and respiratory issues; bronchoalveolar lavage was necessary in 19.7% for diagnosis.

Cite This Study

Izhakian et al. (2025) studied this question.

synapsesocial.com/papers/68c23528b210217d6476f21d https://doi.org/10.21203/rs.3.rs-6909508/v1

View Full Paper

Ask AI

Bookmark

Implication

Observational cohort study reveals high mortality rate and diagnostic challenges in patients with persistent covid-19, highlighting implications for treatment strategies.

Characterization of persistent COVID-19: An emerging post- pandemic crisis in immunocompromised patients. An observational cohort study

Discussion

Member takes

Implication

Key Points

Cite This Study

Characterization of persistent COVID-19: An emerging post- pandemic crisis in immunocompromised patients. An observational cohort study

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider